Skip to main navigation
Skip to search
Skip to main content
Taipei Medical University Home
Help & FAQ,
English
中文
Home
Profiles
Research units
Projects
Research output
Datasets
Activities
Search by expertise, name or affiliation
Preclinical Repurposing of Sitagliptin as a Drug Candidate for Colorectal Cancer by Targeting CD24/CTNNB1/SOX4-Centered Signaling Hub
Jing Wen Shih
,
Alexander T.H. Wu
, Ntlotlang Mokgautsi
,
Po Li Wei
,
Yan Jiun Huang
Master Program in Graduate Institute of Cancer Biology and Drug Discovery
The Ph.D. Program for Translational Medicine
TMU Research Center of Cancer Translational Medicine
Ph.D. Program for Cancer Molecular Biology and Drug Discovery
Taipei Heart Institute (THI), Taipei Medical University
International Ph.D. Program for Translational Science
Graduate Institute of Biomedical Informatics
International Ph.D. Program in Cell Therapy and Regenerative Medicine
TMU Research Center for Digestive Medicine
Taipei Medical University Hospital
Master Program in Clinical Genomics and Proteomics
Graduate Institute of Clinical Medicine
Division of Colorectal surgery
International Master Program for Translational Science
Research output
:
Contribution to journal
›
Article
›
peer-review
8
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Preclinical Repurposing of Sitagliptin as a Drug Candidate for Colorectal Cancer by Targeting CD24/CTNNB1/SOX4-Centered Signaling Hub'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Sitagliptin
100%
Colorectal Cancer
100%
Repurposing
100%
Malignant Neoplasm
62%
Colon Cancer
12%
Cancer Growth
12%
Catenin
12%
Neoplasm
12%
Tumor Microenvironment
12%
Medicine and Dentistry
Sitagliptin
100%
Colorectal Cancer
100%
Cancer Stem Cell
62%
In Vitro
12%
Metastatic Carcinoma
12%
Neoplasm
12%
Cancer
12%
Cancer Therapy
12%
Signaling Molecule
12%
Cancer Growth
12%
Catenin
12%
Colon Cancer
12%
Tumor Microenvironment
12%
Docking (Molecular)
12%
Cancer Associated Fibroblast
12%
Biochemistry, Genetics and Molecular Biology
CD24
100%
SOX4
100%
Cancer Stem Cell
83%
Colon
16%
Fibroblast
16%
Docking (Molecular)
16%
Catenin
16%
Immunology and Microbiology
Cancer Stem Cell
100%
Colon
20%
Molecular Docking
20%
Cancer Associated Fibroblast
20%
Catenin
20%